Acadian Asset Management LLC Sells 219,574 Shares of The Clorox Company (NYSE:CLX)

Acadian Asset Management LLC trimmed its position in shares of The Clorox Company (NYSE:CLX) by 24.9% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 662,952 shares of the company’s stock after selling 219,574 shares during the quarter. Acadian Asset Management LLC’s holdings in Clorox were worth $90,454,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the company. Loudon Investment Management LLC raised its position in Clorox by 7.6% in the 2nd quarter. Loudon Investment Management LLC now owns 5,732 shares of the company’s stock worth $782,000 after purchasing an additional 405 shares during the period. Mine & Arao Wealth Creation & Management LLC. grew its stake in shares of Clorox by 2.8% during the second quarter. Mine & Arao Wealth Creation & Management LLC. now owns 3,403 shares of the company’s stock valued at $464,000 after buying an additional 94 shares during the last quarter. Cullen Frost Bankers Inc. raised its holdings in shares of Clorox by 1,790.4% in the second quarter. Cullen Frost Bankers Inc. now owns 40,512 shares of the company’s stock worth $5,529,000 after buying an additional 38,369 shares during the period. Lake Street Advisors Group LLC lifted its stake in shares of Clorox by 7.0% during the 2nd quarter. Lake Street Advisors Group LLC now owns 1,747 shares of the company’s stock worth $238,000 after acquiring an additional 115 shares during the last quarter. Finally, Advisor OS LLC grew its position in Clorox by 48.1% in the 2nd quarter. Advisor OS LLC now owns 4,594 shares of the company’s stock valued at $627,000 after acquiring an additional 1,493 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.0 %

NYSE CLX opened at $164.75 on Friday. The company has a 50 day moving average price of $142.93 and a 200 day moving average price of $142.85. The firm has a market cap of $20.46 billion, a PE ratio of 85.36, a price-to-earnings-growth ratio of 3.21 and a beta of 0.40. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $166.49.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. The firm had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. As a group, sell-side analysts forecast that The Clorox Company will post 6.56 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th were given a dividend of $1.22 per share. The ex-dividend date of this dividend was Tuesday, August 13th. This represents a $4.88 dividend on an annualized basis and a yield of 2.96%. This is a boost from Clorox’s previous quarterly dividend of $1.20. Clorox’s payout ratio is currently 252.85%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CLX. BNP Paribas initiated coverage on Clorox in a research report on Monday, June 24th. They set an “underperform” rating and a $130.00 target price for the company. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research report on Friday, August 2nd. Wells Fargo & Company dropped their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. TD Cowen began coverage on shares of Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target for the company. Finally, Argus raised Clorox to a “hold” rating in a research note on Tuesday, June 4th. Six investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $143.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.